The new All-Party Parliamentary Group (APPG) on Personalised Medicine is holding its official launch event in the House of Commons tomorrow. The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care.
The PHG Foundation, an independent health policy think tank that aims to make science work for health, provides the Secretariat for the new Group, supported by partners the Northern Health Science Alliance (NHSA), the Wellcome Trust Sanger Institute and the BMJ.
NHSA Chief Executive Dr Hakim Yadi said: “Personalised medicine is the future of the NHS – it is a new better form of healthcare which treats the patient as an individual.
“The North of England, through its excellence in research and innovation, is playing an integral part in developing Personalised Medicine exploring its potential for patients and the NHS.”
Over a hundred stakeholders from the patient community and the clinical, research, policy and commercial sectors will join parliamentarians led by the Group’s Co-Chair Lord Norman Warner to discuss the nature of personalised medicine and implications for the NHS.
APPG Chair Jo Churchill MP said: “As a two time cancer survivor, personalised medicine has been a dream of mine and I am so keen to move this APPG forward…Working closely with my Co-Chair Lord Warner, and the other parliamentary officers and members, I believe this Group will provide a much-needed forum, for productive discussion and insightful debate, on how personalised medicine offers us opportunities to provide a more efficient and effective NHS”.
Delegates will hear from distinguished speakers Prof Peter Johnson (Chief Clinician, Cancer Research UK) and Prof Hugh Watkins (Head of the Department of Medicine, John Radcliffe Hospital, Oxford) on the benefits of personalised medicine for cancer and cardiac patients. There will also be demonstrations of some of the innovative technologies that could help deliver better, more tailored patient care in the near future, including a pocket-sized DNA analyser, a medical 3D printer, a mobile ECG device and a patient-controlled medical records portal.
Related News Articles
£2bn cost of mental ill health in the North
New report finds that mental health in the North was disproportionately affected during the pandemic.
A successful delegation to Biomed Israel 2022
Our Cluster Development Manager, Dr Ben Martyn, reflects on the interactions and opportunities across the week-long delegation.
Guest Blog: Exploring the future of the mental healthcare system
A guest Biomed Israel blog from Heather Rice, Assistant Director of Research, RDaSH NHS Foundation Trust.